Multicentre treatment planning inter-comparison in a national context: The liver stereotactic ablative radiotherapy case

Physica Medica

Volumn 32, Issue 1, 2016, Pages 277-283

  Esposito, Marco ^a   Maggi, Giulia ^b   Marino, Carmelo ^c   Bottalico, Laura ^d   Cagni, Elisabetta ^e   Carbonini, Claudia ^f   Casale, Michelina ^g   Clemente, Stefania ^h   D'Alesio, Valentina ^d   Fedele, David ⁱ   Giglioli, Francesca Romana ^j   Landoni, Valeria ^k   Martinotti, Anna ^l   Nigro, Roberta ^m   Strigari, Lidia ^k   Villaggi, Elena ⁿ   Mancosu, Pietro ^b  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^c Humanitas Catania Oncology Centre   (Italy)

^d Malzoni Radiosurgery Center Salerno   (Italy)

^e Hospital S Maria Nuova   (Italy)

^f Hospital of Milano Niguarda   (Italy)

^g S MARIA HOSPITAL   (Italy)

^h REFERRAL CANCER CENTER OF BASILICATA   (Italy)

ⁱ Casa di Cura San Rossore   (Italy)

^j CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^k REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^l CDI   (Italy)

^m ASL Rieti   (Italy)

ⁿ AUSL Piacenza   (Italy)

more..

Author keywords

Dosimetry; Liver; Multicentric clinical trial; Stereotactic ablative radiotherapy (SABR); Stereotactic body radiation therapy (SBRT)

Indexed keywords

ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONFORMAL RADIOTHERAPY; CORRELATION ANALYSIS; CYBERKNIFE; DOSIMETRY; HEALTH CARE PLANNING; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LIVER METASTASIS; LIVER WEIGHT; PROCESS OPTIMIZATION; STEREOTACTIC BODY RADIATION THERAPY; TOMOTHERAPY; CLINICAL TRIAL; COMPARATIVE STUDY; COMPUTER SIMULATION; FACTUAL DATABASE; FOUR DIMENSIONAL COMPUTED TOMOGRAPHY; ITALY; LIVER NEOPLASMS; METASTASIS; MULTICENTER STUDY; ORGANS AT RISK; PROCEDURES; RADIOMETRY; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING SYSTEM; REPRODUCIBILITY; TREATMENT OUTCOME;

COMPUTER SIMULATION; DATABASES, FACTUAL; FOUR-DIMENSIONAL COMPUTED TOMOGRAPHY; HUMANS; ITALY; LIVER NEOPLASMS; NEOPLASM METASTASIS; ORGANS AT RISK; RADIOMETRY; RADIOSURGERY; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; REPRODUCIBILITY OF RESULTS; TREATMENT OUTCOME;

EID: 84951189864     PISSN: 11201797     EISSN: 1724191X     Source Type: Journal    
DOI: 10.1016/j.ejmp.2015.09.009     Document Type: Article

References (24)

1. Timmerman R.D., Kavanagh B.D., Cho L.C., Papiez L., Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007, 25:947-952.
2. Macdermed D.M., Weichselbaum R.R., Salama J.K. A rationale for the targeted treatment of oligometastases with radiotherapy. J Surg Oncol 2008, 98:202-206.
3. Schefter T.E., Kavanagh B.D., Timmerman R.D., Cardenes H.R., Baron A., Gaspar L.E. A phase I trial of stereotactic body radiation therapy (SBRT) for liver metastases. Int J Radiat Oncol Biol Phys 2005, 62:1371-1378.
4. Katz A.W., Carey-Sampson M., Muhs A.G., Milano M.T., Schell M.C., Okunieff P. Hypofractionated stereotactic body radiation therapy (SBRT) for limited hepatic metastases. Int J Radiat Oncol Biol Phys 2007, 67:793-798.
5. Scorsetti M., Arcangeli S., Tozzi A., Comito T., Alongi F., Navarria P., et al. Is stereotactic body radiation therapy an attractive option for unresectable liver metastases? A preliminary report from a phase 2 trial. Int J Radiat Oncol Biol Phys 2013, 86:336-342.
6. Dawson L.A., Normolle D., Balter J.M., McGinn C.J., Lawrence T.S., Ten Haken R.K. Analysis of radiation induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 2002, 53:810-821.
7. Schefter T.E., Kavanagh B.D. Radiation therapy for liver metastases. Semin Radiat Oncol 2011, 21:264-270. Review Erratum in: Semin Radiat Oncol 2012; 22(1): 86.
8. Herfarth K.K., Debus J., Wannenmacher M. Stereotactic radiation therapy of liver metastases: update of the initial phase-I/ II trial. Front Radiat Ther Oncol 2004, 38:100-105.
9. Lee M.T., Kim J.J., Dinniwell R., Brierley J., Lockwood G., Wong R., et al. Phase I study of individualized stereotactic body radiotherapy of liver metastases. J Clin Oncol 2009, 27:1585-1591.
10. Rusthoven K.E., Kavanagh B.D., Cardenes H., Stieber V.W., Burri A.H., Feigenberg S.J., et al. Multi-institutional phase I/II trial of stereotactic body radiation therapy for liver metastases. J Clin Oncol 2009, 27:1572-1578.
11. Mendez Romero A., Wunderink W., van Os R.M., Nowak P.J., Heijmen B.J., Brandwijk R.P., et al. Quality of life after stereotactic body radiation therapy for primary and metastatic liver tumors. Int J Radiat Oncol Biol Phys 2008, 70:1447-1452.
12. Clemente S., Nigro R., Oliviero C., Marchioni C., Esposito M., Giglioli F.R., et al. Role of the technical aspects of hypofractionated radiation therapy treatment of prostate cancer: a review. Int J Radiat Oncol Biol Phys 2015, 91:182-195.
13. Marino C., Villaggi E., Maggi G., Esposito M., Strigari L., Bonanno E., et al. A feasibility dosimetric study on prostate cancer. Strahlenther Onkol 2015, 191:573-581.
14. Veronese I., De Martin E., Martinotti A.S., Fumagalli M.L., Vite C., Redaelli I., et al. Multi-institutional application of failure mode and effects analysis (FMEA) to CyberKnife stereotactic body radiation therapy (SBRT). Radiat Oncol 2015, 10:132.
15. Mancosu P., Castiglioni S., Reggiori G., Catalano M., Alongi F., Pellegrini C., et al. Stereotactic body radiation therapy for liver tumours using flattening filter free beam: dosimetric and technical considerations. Radiat Oncol 2012, 7:16. 10.1186/1748-717X-7-16.
16. Hoyer M., Romero A.M., van der Linden E., Heijmen B., Lax I., Wunderink W. RAS-trial radiofrequency ablation versus stereotactic body radiation therapy for colorectal liver metastases: a randomized trial Available from:. http://www.cirro.dk/assets/files/CIRRO-IP060109-levermetastaser.pdf.
17. Scorsetti M., Comito T., Tozzi A., Navarria P., Fogliata A., Clerici E., et al. Final results of a phase II trial for stereotactic body radiation therapy for patients with inoperable liver metastases from colorectal cancer. J Cancer Res Clin Oncol 2015, 141(3):543-553. 10.1007/s00432-014-1833-x.
18. Comito T., Cozzi L., Clerici E., Campisi M.C., Liardo R.L., Navarria P., et al. Stereotactic ablative radiotherapy (SABR) in inoperable oligometastatic disease from colorectal cancer: a safe and effective approach. BMC Cancer 2014, 14:619. 10.1186/1471-2407-14-619.
19. Milano M.T., Constine L.S., Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol 2008, 3:36.
20. Gershkevitsh E., Pesznyak C., Petrovic B., Grezdo J., Chelminski K., do Carmo Lopes M., et al. Dosimetric inter-institutional comparison in European radiotherapy centres: results of IAEA supported treatment planning system audit. Acta Oncol 2014, 53(5):628-636.
21. Benedict S.H., Yenice K.M., Followill D., Galvin J.M., Hinson W., Kavanagh B., et al. Stereotactic body radiation therapy: the report of AAPM Task Group 101. Med Phys 2010, 37(8):4078-4101.
22. ICRU Report 83 Prescribing, recordering, adp reporting photon-beam intensity modulated radiation therapy (IMRT). ICRU 2010, 10(1). ISSN 1742-3422.
23. Abacioglu U., Ozen Z., Yilmaz M., Arifoglu A., Gunhan B., Kayalilar N., et al. Critical appraisal of RapidArc radiosurgery with flattening filter free photon beams for benign brain lesions in comparison to GammaKnife: a treatment planning study. Radiat Oncol 2014, 9:119. 10.1186/1748-717X-9-119.
24. Balagamwala E., Suh J., Barnett G., Khan M., Neyman G., Cai R., et al. The importance of the conformality, heterogeneity and gradient indices in evaluating Gamma Knife radiosurgery treatment plans for intracranial meningiomas. Int J Radiat Oncol Biol Phys 2012, 83:1406-1413.